Sign in to view content

It’s the Patient, Not the Agent: An Assessment of Anti-VEGF Extended Dosing Intervals in Patients With nAMD

David A. Eichenbaum, MD, FASRS

Video
Published 2019

Related

Episode 2: Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration with Dr. Brian Ballio
Keyvan Koushan, MD, FRCSC
Member Podcasts
2017
Higher-Order OCT Analysis From the HAWK Study: Longitudinal Dynamics in Fluid Burden, Outer Retinal Integrity, and Subretinal Hyperreflective Material
Justis P. Ehlers, MD, FASRS
On Demand Cases, Courses, and Papers
2021
Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
Emmanuel Chang, MD PhD FACS FASRS
Annual Meeting Talks
2023

Category: AMD-Neovascular

See more